Physiotherapy

FDA clears MagVenture Pain Therapy

MagVenture Pain Therapy is an FDA-cleared solution launched in November 2023, designed for chronic pain relief. It utilizes focused magnetic pulses to stimulate peripheral nerves, offering a non-invasive approach to managing persistent pain. This therapy aims to provide an alternative or adjunctive treatment for patients seeking relief from various chronic pain conditions, leveraging TMS technology in a new application area.

  • FDA-Cleared: Holds FDA clearance for chronic pain relief.
  • Non-invasive: Delivers therapy using focused magnetic pulses.
  • Peripheral Nerve Stimulation: Specifically targets peripheral nerves.
  • Chronic Pain Relief: Indicated for managing chronic pain.
  • Launched: Released in November 2023.